等待开盘 11-14 09:30:00 美东时间
-0.130
-0.41%
今日重点评级关注:韦德布什:维持Cullinan Therapeutics"跑赢大市"评级,目标价从42美元升至44美元;HC Wainwright & Co.:维持WhiteFiber"买入"评级,目标价从34美元升至36美元
11-12 19:19
Mizuho analyst Ann Hynes downgrades Pediatrix Medical Group (NYSE:MD) from Neutral to Underperform and maintains the price target from $28 to $28.
11-11 18:53
Westwood Holdings Group announced monthly income distributions for four of its ETFs: MDST, WEEI, YLDW, and PWRX. The distributions per share are $0.225 for MDST and WEEI, $0.179 for YLDW, and $0.105 for PWRX, with annualized rates of 9.2%, 10.4%, 8.5%, and 5.1% respectively. These ETFs focus on energy infrastructure, broad energy exposure, diverse assets, and power infrastructure. Performance data as of September 2026 shows varying returns since ...
11-05 13:00
今日重点评级关注:Canaccord Genuity:维持Viking Therapeutics"买入"评级,目标价从106美元升至118美元;Canaccord Genuity:维持Aclaris Therapeutics"买入"评级,目标价从10美元升至13美元
11-02 18:53
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 财务业绩: - **净营收(Net Revenue)**:本季度净营收为5.014亿美元,同比增长1.7%,增长主要由收购活动驱动,同时同店营收(same-unit revenue)增长0.6%。 - **调整后EBITDA(Adjusted EBITDA)**:本季度为8550万美元,低于去年同期的8730万美元。 - **调整后每股收益(Adjusted EPS)**:为0.72美元,较2025年第三季度的0.67美元有所增长。 - **薪资与福利支出(Salaries and Benefits)**:本季度为3.415亿美元,临床薪资增长保持在
10-30 13:01
Pediatrix Medical Group 2026 财年第三季度业绩电话会议涵盖了 8500 万美元的调整后 EBITDA、0.6% 的同单位增长以及 2.9 亿至 3 亿美元的业绩展望。
10-29 21:54
Pediatrix Medical Group shares are trading higher after the company reported better-than-expected Q3 financial results.
10-29 21:06
Pediatrix Medical Group (NYSE:MD) reported quarterly earnings of $0.72 per share which beat the analyst consensus estimate of $0.65 by 10.77 percent. This is a 7.46 percent increase over earnings of $0.67 per share from the same period last year. The company reported quarterly sales of $501.374 mill...
10-29 18:13
Pediatrix Medical Group’s Q3 2026 revenue increased 1.7% to $501.4 million, but adjusted EBITDA slipped to $85.5 million as salaries and G&A grew faster than revenue. GAAP EPS fell to $0.59 from $0.84, partly because Q3 2025 included a $20.9 million investment gain, while adjusted EPS rose to $0.72 as the share count declined. Cash from continuing operations was $117.7 million, same-unit revenue grew 0.6%, and full-year adjusted EBITDA guidance w
10-29 10:14
Westwood Holdings Group announced monthly income distributions for three ETFs: MDST, WEEI, and YLDW. MDST and WEEI both distribute $0.225 per share with annualized rates of 9.8% and 11.2%, respectively, while YLDW distributes $0.180 per share at an 8.7% annualized rate. These funds combine dividend yields and options premiums to provide monthly income, targeting energy sector investments. MDST focuses on midstream energy companies, WEEI on broad ...
10-12 12:00